Login to Your Account

Plexxikon Enters Roche Deal On B-Raf Inhibitors For $706M

By Jennifer Boggs

Thursday, October 5, 2006
Earlier this week, Plexxikon Inc.'s president Kathleen Sereda Glaub told BioWorld Today that the company was in "active partnering mode." (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription